Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant topical estriol with solifenacin in postmenopausal women with overactive bladder
TCTR20260731009Phase 3Completed
- Sponsor
- Dzicky Rifqi Fuady (Researcher)
- Start
- Jun 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of estriol, solifenacin in overactive bladder (OAB), sponsored by Dzicky Rifqi Fuady (Researcher). Started Jun 2023; status: completed.
02
Drugs
estriolsolifenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on TCTR20260731009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260731009.